Myeloma Minute: Latest on Myeloma Risk Factors


| INNOVATION | Latest Research


New Studies Point to Increased Risk of MGUS in Firefighters Exposed to 9/11 Carcinogens

Firefighters who responded to the World Trade Center terrorist attack are twice as likely to develop the myeloma precursor state MGUS. This and other research news, says IMF Chairman Dr. Brian G.M. Durie, underscore the fact that “our environment and our bodies are in a delicate balance of biochemical reactions that must be protected from dramatic shifts.”


| EDUCATION | For Patients


Patients Can Now Listen to Excerpts from This Ask Dr. Durie Doctors’ Edition

Now available from Medscape Oncology are excerpts from a CME (continuing medical education) activity for hematologists and oncologists moderated by International Myeloma Foundation Chairman Brian G.M. Durie, MD. The first videos focus on “Proteasome Inhibitors in Multiple Myeloma.” Myeloma experts Shaji Kumar, MD; Thomas Martin, MD; Joseph Mikhael, MD; and Saad Usmani, MD; provide expert insights to improve selection of proteasome inhibitor-based therapy for patients with multiple myeloma. Patients can now learn from these educational videos as well.


| INSPIRATION | Mother's Day


| INSPIRATION | Myeloma Voices


Shop Amazon This Mother’s Day and Give to the IMF at the Same Time
For Myeloma Patient Daniel Neidert, “Knowledge Is Power”

Whether you shop Amazon this Mother’s Day (Sunday, May 13th) or for your daily needs, please bookmark When you shop at this link, Amazon will donate a percentage of your total purchase to the IMF, at no added cost to you. Donating to the IMF this Mother’s Day is as easy as a point-and-click.

Dan Neidert was diagnosed with multiple myeloma in 2013. After an unsuccessful transplant, he was put on a different treatment regimen. Since then, he has been living symptom-free. Dan now advises, “The more knowledge you have, the better you are going to be. As a patient, you will definitely have better outcomes because you will be able to decide what’s best going forward.” Watch Dan’s story about his journey of living with myeloma.



| EDUCATION | Myeloma Today


Hot Off the Press: Myeloma Today

This quarter’s Myeloma Today journal is available free to download as a pdf! You can also receive a free printed copy in the mail. The Spring edition includes a discussion of antibody therapies in myeloma, as well as the expanded approval of Xgeva® and news on the use of Darzalex®, Kyprolis®, Pomalyst®, and selinexor.


| EDUCATION | Translations


Scientific & Clinical News in Multiple Languages

Did you know that important medical articles from the IMF’s Myeloma Today journal are available in French, Italian, German, and Spanish?

Visit our International Publications library today.


| INNOVATION | Research Grant


Calling All Researchers: Submit Your Grant Applications!

The Brian D. Novis Research Grants honor the IMF’s founder Brian Novis, who passed of multiple myeloma in July of 1992. The grants are awarded to researchers in the field of multiple myeloma and related disorders including smoldering multiple myeloma (SMM), monoclonal gammopathy of undetermined significance (MGUS), and immunoglobulin-derived amyloidosis. The 2019 grants will fund senior research projects with $80,000 each and junior research projects with $50,000 each. The deadline for applications is Wednesday, August 1, 2018.


| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series



BOSTON Trial Fact Sheet

New isatuximab Clinical Trial: the IMROZ Study

New isatuximab Clinical Trial: the IKEMA Study

New ixazomib Clinical Trials: Learn How to Participate

Join the conversation about myeloma on the Smart Patients Message Board

May 5-6, 2018
Miracles Happen When Pigs Fly!
Cincinnati, OH

May 12, 2018
IMF Regional Community Workshop
Seattle, WA

June 2, 2018
11th Annual Carolyn Czerkies Memorial Golf Outing
Joliet, IL

June 9, 2018
IMF Regional Community Workshop
Indianapolis, IN


subscribe_button.png          donate_button_bottom.png
We Thank Our Sponsors:
Amgen, Celgene Corporation, Genentech, Janssen Oncology, and Takeda Oncology
and individuals like you who supported the IMF this year

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.